Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+3.62%
-2.90%
+0.46%
-1.28%
ALXO
ALX Oncology Holding
$1.87
Login to display ALX Oncology Holding (ALXO) recommendation from the last 90 days from financial news and social media. Strengths
Earnings are forecast to grow
Chart
$1.03 (+81.55%)
$0.44 (+325.00%)
$0.48 (+289.58%)
$1.54 (+21.43%)
ALXO has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Price under $5
High volatilty
ALXO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
ALXO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ALXO Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayALXO Earnings
The TTM reflects 12-month period, providing review of ALXO financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
PFE
23.76
+0.68%
GSK
39.85
+0.84%
ELVN
20.01
+7.75%
AZN
73.76
+0.31%
What is ALXO current stock price?
What are ALXO stock strengths?
What risks are associated with ALXO stock?
When is ALXO next earnings report?
What is ALXO market cap and volume?
What is ALXO's current Stock IQ?
Should I buy ALXO stock right now?
Is ALXO a Strong Buy right now?
What does a 'Strong Buy' rating mean for ALXO?
What does a 'Strong Sell' rating mean for ALXO?
What factors influence ALXO's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+3.62%
-2.90%
+0.46%
-1.28%
ALXO
ALX Oncology Holding
Current Price
$1.87
Stock Insights
Strengths
Earnings are forecast to grow
Linked to ALXO
PFE
23.76
+0.68%
GSK
39.85
+0.84%
ELVN
20.01
+7.75%
AZN
73.76
+0.31%
Login to view ALX Oncology Holding (ALXO) recommendation from the last 90 days from financial news and social media.
Chart
$1.03 (+81.55%)
$0.44 (+325.00%)
$0.48 (+289.58%)
$1.54 (+21.43%)
ALXO Analysts Opinion
ALXO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
ALXO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ALXO Street view is extremely bullish and have positive views on the near-term outlook
ALXO has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Price under $5
High volatilty
Average key support and resistance price levels.
Login to displayALXO Earnings
The TTM data reflects the most recent 12-month period, providing overview of ALXO financial performance.
ALXO Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
ALXO Latest Analysis
ALX Oncology Appoints Board Member Barbara Klencke M.D. as Interim Chief Medical Officer. Dr. Barbara Klencke is an accomplished clinical leader with a distinguished track record in oncology drug development who currently serves on the Company'.s Board of Directors and will step down from the Board to join ALX as Interim Chief Medical Officer Alan Sandler M.D. resigns as Chief Medical Officer and will return to his position serving on the Company'.s Board of Directors SOUTH SAN FRANCISCO
Fri Sep 12, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ALXO Stock trends
ALXO Stock performance
ALXO Stock analysis
ALXO investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings